Botulinum toxin type A on oral health in treating sialorrhea in children with cerebral palsy: A randomized, double-blind, placebo-controlled study

Journal of Child Neurology

Volumn 26, Issue 7, 2011, Pages 838-843

  Wu, Katie Pei Hsuan ^a   Ke, Jyh Yuh ^a   Chen, Chung Yao ^a   Chen, Chia Ling ^a,b   Chou, Ming Yen ^a   Pei, Yu Cheng ^a,c  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

botulinum toxin type A; cerebral palsy; oral health; salivary composition; sialorrhea

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ARTICLE; BACTERIAL COUNT; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DROOLING SCALE; ECHOGRAPHY; FEMALE; FLOW RATE; FOLLOW UP; HUMAN; HYPERSALIVATION; LOW DRUG DOSE; MALE; PAROTID GLAND; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SALIVA ANALYSIS; SALIVARY FLOW RATE; SCHOOL CHILD; SUBMANDIBULAR GLAND; THERAPY EFFECT;

ADOLESCENT; BOTULINUM TOXINS, TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NEUROTOXINS; PILOT PROJECTS; PLACEBOS; SALIVA; SIALORRHEA;

EID: 79959717426     PISSN: 08830738     EISSN: 17088283     Source Type: Journal    
DOI: 10.1177/0883073810395391     Document Type: Article

References (33)

1. van der Burg J, Jongerius PH, van Limbeek J, et al. Social interaction and self-esteem of children with cerebral palsy after treatment for severe drooling. Eur J Pediatr. 2006;165:37-41. (Pubitemid 41830886)
2. Tahmassebi JF, Curzon ME, Curzon MEJ. Prevalence of drooling in children with cerebral palsy attending special schools. Dev Med Child Neurol. 2003;45(9):613-617.
3. Jongerius PH, van den Hoogen FJ, van Limbeek J, et al. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics. 2004;114(3):620-627. (Pubitemid 41529515)
4. Bothwell JE, Clarke K, Dooley JM, et al. Botulinum toxin A as a treatment for excessive drooling in children. Pediatr Neurol. 2002;27(1):18-22. (Pubitemid 34826569)
5. Cotton RT, Richardson MA. The effect of submandibular duct rerouting in the treatment of sialorrhea in children. Otolaryngol Head Neck Surg. 1981;89(4):535-541. (Pubitemid 12201074)
6. Pal PK, Calne DB, Calne S, Tsui JK. Botulinum toxin A as treatment for drooling saliva in PD. Neurology. 2000;54(1): 244-247. (Pubitemid 30038773)
7. Tan EK. Botulinum toxin treatment of sialorrhea: comparing different therapeutic preparations. Eur J Neurol. 2006;13(suppl 1): 60-64.
8. Wu KP, Ke J-Y, Chung C-Y, et al. Relationship between unstimulated salivary flow rate and saliva composition of healthy children in Taiwan. Chang Gung Med J. 2008;31(3):281-286. (Pubitemid 351841547)
9. Gopinath VK, Arzreanne AR. Saliva as a diagnostic tool for assessment of dental caries. Arch Orofac Sci. 2006;1:57-59.
10. Bardow A, Nyvad B, Nauntofte B. Relationships between medication intake, complaints of dry mouth, salivary flow rate and composition, and the rate of tooth demineralization in situ. Arch Oral Biol. 2001;46(5):413-423. (Pubitemid 32289671)
11. Farsi N. Dental caries in relation to salivary factors in Saudi population groups. J Contemp Dent Pract. 2008;9(3):16-23.
12. Brambilla E, Twetman S, Felloni A, et al. Salivary mutans streptococci and lactobacilli in 9- and 13-year-old Italian schoolchildren and the relation to oral health. Clin Oral Investig. 1999; 3(1):7-10.
13. Zhang Q, Bian Z, Fan M, van Palenstein Helderman WH. Salivary mutans streptococci counts as indicators in caries risk assessment in 6-7-year-old Chinese children. J Dent. 2007; 35(2):177-180.
14. Gabris K, Nyarasdy I, Banoczy J, et al. Significance of assessing risk factors for caries in their prevention. Orvosi Hetilap. 2002; 143(24):1467-1473.
15. Oncag O, Alpoz AR, Eronat C. Salivary. Streptococcus mutans. lactobacilli levels and buffer capacity in children with esophageal burns. J Clin Pediatr Dent. 2000;24(2):147-151.
16. Lin Y-C, Lin I-L, Chiu Y-T, Shieh J-Y. Botulinum toxin type A treatment for drooling in Taiwanese children with cerebral palsy: three case reports. Tw J Phys Med. 2007;35(3):165-170.
17. Wilken B, Aslami B, Backes H. Successful treatment of drooling in children with neurological disorders with botulinum toxin A or B. Neuropediatrics. 2008;39(4):200-204.
18. Alrefai AH, Aburahma SK, Khader YS. Treatment of sialorrhea in children with cerebral palsy: a double-blind placebo controlled trial. Clin Neurol Neurosurg. 2009;111(1):79-82.
19. Vaile L, Finlay F. Is injection of botulinum toxin type A effective in the treatment of drooling in children with cerebral palsy? Arch Dis Child. 2006;91(10):862-863.
20. Hassin-Baer S, Scheuer E, Buchman AS, et al. Botulinum toxin injections for children with excessive drooling. J Child Neurol. 2005;20(2):120-123. (Pubitemid 40484851)
21. Banerjee KJ, Glasson C, O'Flaherty SJ. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Dev Med Child Neurol. 2006;48(11): 883-887. (Pubitemid 44596980)
22. Sriskandan N, Moody A, Howlett DC. Ultrasound-guided submandibular gland injection of botulinum toxin for hypersalivation in cerebral palsy. Br J Oral Maxillofac Surg. 2010;48(1):58-60.
23. Hopewell S, Clarke M, Moher D, et al. CONSORT for reporting randomised trials in journal and conference abstracts. Lancet. 2008;371(9609):281-283.
24. Palisano R, Rosenbaum P, Walter S, et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997; 39(4):214-223. (Pubitemid 27226331)
25. Ellies M, Laskawi R, Rohrbach-Volland S, et al. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies. J Oral Maxillofac Surg. 2003; 61(4):454-457. (Pubitemid 36396973)
26. Moller E, Karlsborg M, Bardow A, et al. Botulinum toxin into salivary glands - salivary flow and composition. http://iadr.confex.com/iadr/2004Hawaii/ techprogram/abstract-44904.htm.
27. Kim H, Lee Y, Weiner D, et al. Botulinum toxin type a injections to salivary glands: combination with single event multilevel chemoneurolysis in 2 children with severe spastic quadriplegic cerebral palsy. Arch Phys Med Rehabil. 2006;87(1):141-144. (Pubitemid 43053319)
28. Jongerius PH, Rotteveel JJ, van Limbeek J, et al. Botulinum toxin effect on salivary flow rate in children with cerebral palsy. Neurology. 2004;63(8):1371-1375. (Pubitemid 39426267)
29. Suskind DL, Tilton A, Suskind DL, Tilton A. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy. Laryngoscope. 2002;112(1):73-81. (Pubitemid 34037741)
30. Ellies M, Laskawi R, Rohrbach-Volland S, et al. Botulinumtoxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands. Laryngoscope. 2002; 112(1):82-86. (Pubitemid 34037742)
31. Fuster Torres MA, Berini Aytes L, Gay Escoda C, et al. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Med Oral Patol Oral Cir Bucal. 2007;12(7): E511-E517.
32. Jongerius PH, Rotteveel JJ, van den Hoogen F, et al. Botulinum toxin A: a new option for treatment of drooling in children with cerebral palsy. Presentation of a case series. Eur J Pediatr. 2001;160(8):509-512. (Pubitemid 32695833)
33. Lin YC, Shieh JY, Cheng ML, et al. Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy. Neurology. 2008;70(4):316-318. (Pubitemid 351156812)